The Peter Attia DrivePeter Attia, MDAll episodes
#415 ‒ AMA #91: Understanding lab testing: what blood work can and cannot tell you about your health and disease risk
View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this "Ask Me Anything" (AMA) episode, Peter explores what laboratory testing can—and cannot—tell us about our health. Blood tests provide objective numbers and reference ranges, making them an appealing way to assess overall health. But their usefulness is far more nuanced than it may appear. Peter begins by explaining how to interpret lab results in the context of both lifespan and healthspan, emphasizing the importance of tracking changes over time rather than relying on isolated measurements. He then examines the strengths and limitations of blood testing for assessing risk across the major chronic diseases, including cardiovascular disease, metabolic dysfunction, cancer, and neurodegenerative disease. He explains what labs can reveal about organ health and where additional information from imaging, body composition, and functional testing is needed. The conversation also explores why more testing does not necessarily lead to better clinical decisions. Peter discusses the limitations of large direct-to-consumer testing panels and sophisticated measures such as lipid subfractionation and biological-age scores, particularly when the results lack clear clinical actionability. He also highlights the importance of physical function, cognitive performance, and emotional health—critical components of healthspan that cannot be adequately captured through blood work alone. Finally, Peter provides a practical framework for evaluating any laboratory test, understanding its limitations, and determining whether the results offer meaningful information that can guide decisions about health and longevity.
If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #91 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.
We discuss:
- Why lab testing is insufficient to answer the question "Am I healthy?" [2:15];
- Defining health through the lenses of lifespan, health span, and fundamental organ systems, and how labs can come up short [5:45];
- The importance of longitudinal data, and the strengths and blind spots of labs for assessing cardiovascular disease risk [10:00];
- Using labs to assess metabolic health, and the additional insights from body composition, behavior, and functional testing [18:45];
- What blood tests and genetic testing can reveal about cancer detection and future cancer risk [23:00];
- Assessing neurodegenerative disease risk through genetics, cardiometabolic markers, and emerging blood-based biomarkers [28:00];
- What routine labs reveal about organ systems, and how to evaluate large direct-to-consumer testing panels [35:00];
- Sophisticated tests that lack clinical actionability: lipid subfractionation, biological-age scores, and sleep scores [41:30];
- Why la
